Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus

Stopped early · Phase 3

Conditions studied: Subjective Tinnitus

In brief

The purpose of this study is to investigate the long-term safety and tolerability and efficacy of neramexane mesylate in the long-term treatment of subjective tinnitus after a completed double-blind randomized placebo controlled study

Key facts

Study ID
NCT00827008
Run by
Merz Pharmaceuticals GmbH
People needed
821
Starts
2009-01-01
Expected to finish
2011-12-01
Last updated by the study team
2012-11-28

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.